David J Curtis

26PUBLICATIONS
84CO-AUTHORS
HaematologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Dec 18, 2025
Posttransplant cyclophosphamide in HLA-matched peripheral blood transplantation: what's next?

David J Curtis, Geoffrey R Hill

|Nov 03, 2025
Factors Associated with Risk of Clonal Haematopoiesis of Indeterminate Potential: A Systematic Review and Meta-Analysis.

Jasmine Singh, Nancy Li, Elham Ashrafi

|Jun 13, 2025
Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and Cyclosporin.

David J Curtis, Sushrut S Patil, John Reynolds

|May 13, 2025
Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs.

Julie A I Thoms, Feng Yan, Henry R Hampton

|Jan 23, 2025
Targeting LMO2-induced autocrine FLT3 signaling to overcome chemoresistance in early T-cell precursor acute lymphoblastic leukemia.

Cedric S Tremblay, Jesslyn Saw, Feng Yan

|Jun 05, 2024
Clonal hematopoiesis of indeterminate potential as a prognostic factor: a systematic review and meta-analysis.

Jasmine Singh, Nancy Li, Elham Ashrafi

Pageof 5

Frequent Collaborators

6 joint publications

Cedric S Tremblay

4 joint publications

Feng Yan

4 joint publications

John E Pimanda

3 joint publications

Benjamin T Kile